Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01177 SINO BIOPHARM
RTNominal up3.020 +0.010 (+0.332%)
Others

21/01/2020 17:51

Sino Biopharm (01177) unit signs agreement with Octapharma

[ET Net News Agency, 21 January 2020] Sino Biopharmaceutical Limited (01177) said its
subsidiary Nanjing Chia Tai Weikang Biopharmaceutical Co Limited has entered into a
distribution agreement with Octapharma AG (Octapharma). It will act as an exclusive
distributor in the PRC of the human albumin products produced by Octapharma for an initial
term of three years.
Octapharma is one of the largest human protein manufacturers in the world, which
develops and produces human protein products sourced from human plasma and human cell
lines. Headquartered in Lachen, Switzerland, Octapharma has the largest independent plasma
fractionator in the world. (RC)

Remark: Real time quote last updated: 28/03/2024 18:00
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.